| Property |
Value |
| Protein Name |
DNA-PKcs (DNA-Dependent Protein Kinase Catalytic Subunit) |
| Gene |
PRKDC |
| UniProt ID |
P78527 |
| PDB Structures |
1JQT, 3KGV, 5W5R |
| Molecular Weight |
469 kDa (4,127 amino acids) |
| Subcellular Localization |
Nucleus (nuclear matrix), cytoplasm |
| Protein Family |
PI3/PI4-related protein kinase family |
| Chromosomal Location |
8q11.21 |
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a serine/threonine protein kinase that plays a critical role in the cellular DNA damage response (DDR). As the catalytic subunit of the DNA-dependent protein kinase (DNA-PK) complex, DNA-PKcs forms a heterotrimeric holoenzyme with the Ku70/Ku80 heterodimer to mediate non-homologous end joining (NHEJ), the predominant pathway for repairing double-strand breaks (DSBs) in mammalian cells.
Beyond its well-established function in DNA repair, DNA-PKcs has emerged as a key regulator of neuronal viability and stress response. Neurons are particularly vulnerable to DNA damage due to their post-mitotic state and high metabolic activity, which generates significant oxidative stress. Accumulating evidence links DNA-PKcs dysfunction to the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions.
Recent research has revealed that DNA-PKcs participates in additional cellular processes beyond DNA repair, including:
- Regulation of telomere length and stability
- V(D)J recombination in lymphocyte development
- Transcriptional regulation through chromatin remodeling
- Mitochondrial function and cellular metabolism
- Tau phosphorylation in AD pathogenesis
- Stress granule formation in response to cellular stress
¶ Structure and Mechanism
¶ Domain Architecture
DNA-PKcs is one of the largest known protein kinases, comprising 4,127 amino acids with a molecular weight of approximately 469 kDa. The protein contains multiple functional domains:
N-terminal Regulatory Domain:
The N-terminal region contains the catalytic subunit's regulatory components:
- Three HEAT repeats that mediate protein-protein interactions
- A Ku-binding domain that interacts with the Ku70/Ku80 heterodimer
- A leucine-rich repeat (LRR) region involved in DNA binding
- A C-terminal region containing the kinase domain
Kinase Domain (C-terminal):
The C-terminal ~380 amino acids constitute the serine/threonine protein kinase domain:
- Belongs to the PI3/PI4-related protein kinase family
- Kinase activity is DNA-dependent, requiring DNA binding for activation
- Contains the activation loop and P+1 loop typical of AGC family kinases
- Autophosphorylation at multiple sites (Ser2056, Thr2609, Ser2056) regulates activity
DNA-Binding Domain:
DNA-PKcs contains specialized domains for DNA binding:
- N-terminal DNA-binding domain
- Ku heterodimer serves as DNA damage sensor
- DNA binding induces conformational changes activating kinase
DNA-PKcs activation follows a well-characterized pathway:
- DNA damage detection: DSBs are sensed by the Ku70/Ku80 heterodimer, which rapidly binds to DNA ends
- Recruitment of DNA-PKcs: DNA-PKcs is recruited to the DNA-Ku complex through protein-protein interactions
- Conformational activation: DNA binding induces a conformational change in DNA-PKcs, exposing the kinase domain
- Autophosphorylation: DNA-PKcs undergoes autophosphorylation at multiple sites, stabilizing the active conformation
- Substrate phosphorylation: Activated DNA-PKcs phosphorylates downstream targets involved in DNA repair, transcription, and cell survival
¶ DNA Double-Strand Break Repair (NHEJ)
DNA-PKcs is the central effector kinase in the classical non-homologous end joining (c-NHEJ) pathway:
Core NHEJ Pathway:
- Ku70/Ku80 heterodimer binds DNA ends (within seconds of damage)
- DNA-PKcs recruited and activated by DNA-Ku complex
- DNA-PKcs phosphorylates downstream effectors (XRCC4, Ligase IV, XLF, Artemis)
- DNA ends processed and ligated by Ligase IV/XRCC4/XLF complex
- DNA-PKcs activity regulated by autophosphorylation (Ser2056, Thr2609)
Alternative End Joining (alt-NHEJ):
When c-NHEJ is compromised, cells resort to alternative pathways:
- Microhomology-mediated end joining (MMEJ)
- DNA-PKcs-independent pathways can partially compensate
In developing lymphocytes, DNA-PKcs is essential for V(D)J recombination:
- Required for antigen receptor gene rearrangement
- Mutations in PRKDC cause severe combined immunodeficiency (SCID) in mice and humans
- Defective V(D)J recombination leads to immunodeficiency
DNA-PKcs modulates gene expression through:
Chromatin Remodeling:
- Phosphorylates histone H2AX (forming γ-H2AX)
- Recruits chromatin remodeling complexes
- Facilitates transcriptional reprogramming after DNA damage
RNA Polymerase II Regulation:
- Phosphorylates RNA Pol II C-terminal domain
- Coordinates transcription with DNA repair
- Regulates expression of stress response genes
¶ Telomere Maintenance
DNA-PKcs contributes to telomere stability:
- Localizes to telomeres through Ku interaction
- Prevents telomere end-to-end fusions
- Maintains telomere length in proliferating cells
In post-mitotic neurons, DNA-PKcs has specialized functions:
DNA Damage Repair:
- Neurons rely on NHEJ for DSB repair (no homologous recombination)
- DNA-PKcs is the primary DSB repair kinase in neurons
- Critical for neuronal survival given high oxidative stress
Stress Response:
- Regulates stress-activated signaling pathways
- Participates in stress granule formation
- Modulates neuronal responses to oxidative stress
Metabolic Regulation:
- Links metabolic status to DNA integrity
- DNA-PKcs activity affected by cellular energy state
- May influence neuronal plasticity
DNA-PKcs has emerged as a significant player in AD pathogenesis:
DNA Damage Accumulation:
AD brains show elevated levels of DNA damage, including DSBs:
- Oxidative stress generates persistent DNA damage in neurons
- DNA repair capacity declines with age and in AD
- DNA-PKcs activity is reduced in AD brains
- Accumulated DNA damage contributes to neuronal dysfunction and death
Tau Pathology:
A critical discovery links DNA-PKcs to tau phosphorylation:
- DNA-PKcs directly phosphorylates tau at multiple sites
- Thr262, Ser356, and Ser396 are DNA-PKcs phosphorylation sites
- Hyperphosphorylated tau is a hallmark of AD neurofibrillary tangles
- DNA-PKcs activity is elevated in AD brains, promoting tau pathology
- DNA-PKcs inhibition reduces tau phosphorylation in cellular models
Amyloid-Beta Effects:
- Aβ exposure increases neuronal DNA damage
- DNA-PKcs activation is part of the Aβ-induced stress response
- DNA-PKcs may link Aβ toxicity to downstream tau pathology
Therapeutic Implications:
- DNA-PKcs inhibitors have shown neuroprotective effects in AD models
- Reducing DNA-PKcs activity decreases tau phosphorylation
- However, completely inhibiting DNA repair may have adverse effects
DNA-PKcs involvement in PD has been increasingly recognized:
Dopaminergic Neuron Vulnerability:
- Dopaminergic neurons in the substantia nigra are particularly vulnerable
- These neurons accumulate DNA damage with aging
- DNA-PKcs activity may be dysregulated in PD
Alpha-Synuclein Interaction:
- DNA-PKcs may be affected by α-synuclein pathology
- Lewy bodies contain DNA damage response proteins
- DNA-PKcs may contribute to α-synuclein-induced toxicity
Mitochondrial DNA Damage:
- PD is associated with mitochondrial dysfunction
- Mitochondrial DNA (mtDNA) damage accumulates in PD
- DNA-PKcs may participate in mtDNA repair pathways
- Impaired mtDNA repair contributes to energy failure
LRK2 Interaction:
- LRRK2 mutations are a major cause of familial PD
- DNA-PKcs and LRRK2 may have overlapping functions
- Both kinases are involved in neuronal stress response
Amyotrophic Lateral Sclerosis (ALS):
Motor neurons are particularly vulnerable to DNA damage due to their large size, high metabolic demand, and dependence on efficient DNA repair mechanisms:
- Motor neurons accumulate DNA damage in ALS
- DNA-PKcs activity is altered in ALS models
- DNA repair deficiency may contribute to motor neuron death
- Sporadic and familial ALS show evidence of DNA repair impairment
- DNA-PKcs dysfunction may exacerbate motor neuron vulnerability
Huntington's Disease (HD):
The polyglutamine expansion in mutant huntingtin protein promotes genomic instability:
- Mutant huntingtin promotes DNA damage through multiple mechanisms
- DNA-PKcs dysregulation in HD models
- DNA repair deficits are an early event in HD pathogenesis
- DNA-PKcs activity may be impaired in HD patient tissues
- Enhancing DNA repair capacity is a therapeutic strategy under investigation
Multiple Sclerosis:
Oligodendrocytes are the myelin-producing cells that are targeted in MS:
- DNA damage accumulates in oligodendrocytes in MS
- DNA-PKcs may be involved in demyelination processes
- Myelin repair requires DNA repair capacity
- DNA-PKcs dysfunction may impair oligodendrocyte precursor differentiation
Ataxia-Telangiectasia:
This autosomal recessive disorder is caused by ATM mutations:
- ATM deficiency causes progressive neurodegeneration
- DNA-PKcs can partially compensate for ATM loss
- Combined deficiencies cause severe neurological phenotypes
- ATM and DNA-PKcs have overlapping functions in the DNA damage response
flowchart TD
A["DNA Double-Strand<br/>Break"] --> B["Ku70/Ku80<br/>Binding"]
B --> C["DNA-PKcs<br/>Recruitment"]
C --> D["DNA-PKcs<br/>Activation"]
D --> E["Autophosphorylation<br/>Ser2056, Thr2609"]
E --> F["Downstream<br/>Signaling"]
F --> G["NHEJ Repair<br/>Pathway"]
F --> H["Transcription<br/>Regulation"]
F --> I["Cell Cycle<br/>Checkpoints"]
F --> J["Apoptosis<br/>Regulation"]
G --> K["XRCC4/Ligase IV<br/>Recruitment"]
G --> L["DNA End<br/>Ligation"]
K --> M["DNA Damage<br/>Resolution"]
H --> N["RNA Pol II<br/>Phosphorylation"]
H --> O["Chromatin<br/>Remodeling"]
N --> P["Stress Response<br/>Gene Expression"]
I --> Q["Cell Cycle<br/>Arrest"]
I --> R["DNA Repair<br/>Checkpoint"]
J --> S["Survival<br/>Signaling"]
J --> T["Apoptotic<br/>Pathways"]
U["AD Pathology"] --> V["DNA Damage<br/>Accumulation"]
U --> W["Tau<br/>Hyperphosphorylation"]
V --> X["DNA-PKcs<br/>Dysregulation"]
W --> X
X --> Y["Neuronal<br/>Dysfunction"]
X --> Z["Tau Pathology<br/>Progression"]
AA["PD Pathology"] --> AB["Oxidative Stress"]
AA --> AC["Mitochondrial<br/>Dysfunction"]
AB --> AD["DNA Damage<br/>Accumulation"]
AC --> AD
AD --> AE["DNA-PKcs<br/>Activation"]
AE --> AF["Dopaminergic<br/>Neuron Death"]
Targeting DNA-PKcs in neurodegeneration presents both opportunities and challenges:
Inhibitor Development:
Several DNA-PKcs inhibitors have been developed:
- NU7441: Potent and selective DNA-PKcs inhibitor
- KU-0060648: Dual PI3K/DNA-PKcs inhibitor
- CC-115: DNA-PKcs inhibitor in clinical trials for cancer
- M3814 (Peposertib): Clinical-stage DNA-PKcs inhibitor
Neuroprotective Strategies:
- Low-dose DNA-PKcs inhibition may reduce tau pathology
- Temporary inhibition during acute stress phases
- Combination approaches with other therapeutic agents
¶ Challenges and Considerations
Dual Nature of DNA-PKcs Inhibition:
- Beneficial: Reduces tau phosphorylation, limits DNA damage signaling
- Risky: Impairs DNA repair, potentially increasing genomic instability
Therapeutic Window:
- Identifying optimal dosing for neuroprotection
- Balancing DNA repair capacity with pathological signaling
- Tissue-specific targeting (CNS vs. peripheral)
Alternative Approaches:
- Targeting downstream effectors rather than DNA-PKcs directly
- Modulating DNA-PKcs activity through allosteric mechanisms
- Enhancing DNA repair capacity through other pathways
Preclinical Studies:
- DNA-PKcs inhibitors in AD mouse models show reduced tau pathology
- Genetic knockdown of DNA-PKcs improves cognitive function in AD models
- Combination therapy with Aβ-targeting agents
Clinical Translation:
- Blood-brain barrier penetration is a major challenge
- Prodrug strategies for CNS delivery
- Biomarker development for patient selection
| Partner |
Interaction Type |
Functional Significance |
| Ku70/KU70A |
Direct binding |
DNA damage sensing, complex assembly |
| Ku80/KU80B |
Direct binding |
DNA damage sensing, complex assembly |
| XRCC4 |
Phosphorylation |
DNA end joining |
| Ligase IV |
Phosphorylation |
DNA ligation |
| Artemis |
Phosphorylation |
DNA end processing |
| XLF |
Interaction |
DNA repair scaffold |
| ATM |
Sequential activation |
DSB response coordination |
| DNA-PKcs |
Autophosphorylation |
Self-regulation |
| Tau |
Phosphorylation |
AD pathogenesis |
| RNA Pol II |
Phosphorylation |
Transcription regulation |
| p53 |
Phosphorylation |
Apoptosis regulation |
-
Meek et al. (2004): Comprehensive review establishing DNA-PKcs as the central effector of NHEJ, with fundamental insights into activation mechanism and cellular functions.
-
Bhattacharyya et al. (2005): Landmark review connecting DNA damage response defects to neurodegeneration, establishing DNA-PKcs as a key player in neuronal survival.
-
Mathew et al. (2007): First demonstration of DNA-PKcs deficiency in AD brains, showing reduced kinase activity and impaired DNA repair capacity.
-
Khurana et al. (2017): Breakthrough discovery that DNA-PKcs directly phosphorylates tau at AD-relevant sites, linking DNA damage to tau pathology.
-
Zhang et al. (2023): Confirmed DNA-PKcs-mediated tau phosphorylation in human AD brains, supporting therapeutic targeting.
- DNA-PKcs inhibitors for AD treatment
- Genetic manipulation of DNA-PKcs in neurodegeneration models
- Biomarker development for DNA-PKcs activity
- CNS delivery of DNA-PKcs-targeted compounds
- Combination therapies targeting multiple pathways
| Feature |
DNA-PKcs |
ATM |
ATR |
| Gene |
PRKDC |
ATM |
ATR |
| Primary Function |
NHEJ DSB repair |
DSB checkpoint |
Replication stress |
| Activation |
DNA binding |
DSB detection |
RPA-coated ssDNA |
| Neuronal Role |
Major DSB repair |
Checkpoint control |
Replication stress |
| AD Involvement |
Tau phosphorylation, DNA repair |
DNA repair, checkpoint |
Replication stress |
| Inhibitors |
NU7441, M3814 |
KU-55933 |
VE-822 |
Both ATM and DNA-PKcs are PI3/PI4-related kinases involved in DNA damage response. ATM primarily functions as a checkpoint kinase, while DNA-PKcs is the central effector of NHEJ. In neurons, DNA-PKcs is particularly important due to their reliance on NHEJ for DNA repair.
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a 469 kDa serine/threonine kinase that plays essential roles in DNA double-strand break repair through the non-homologous end joining pathway. Originally characterized for its DNA repair functions, DNA-PKcs has emerged as a key player in neurodegenerative diseases, particularly Alzheimer's disease where it directly phosphorylates tau protein at disease-relevant sites. In Parkinson's disease, DNA-PKcs contributes to dopaminergic neuron vulnerability through DNA damage accumulation and mitochondrial dysfunction.
The therapeutic targeting of DNA-PKcs in neurodegeneration presents a complex challenge due to its dual role in both promoting pathology (through tau phosphorylation) and maintaining neuronal survival (through DNA repair). Ongoing research focuses on developing brain-penetrant DNA-PKcs inhibitors that can modulate pathological signaling while preserving sufficient DNA repair capacity. Understanding the precise context-dependent roles of DNA-PKcs will be critical for developing effective neuroprotective strategies.